Angiotensin Converting Enzyme (ACE) Inhibitors Strategic Research Report 2024-2030: Increasing Focus on Lifestyle Management and Preventive Care Sustains Demand f
October 30, 2024 11:48 ET
|
Research and Markets
Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The "Angiotensin Converting Enzyme (ACE) Inhibitors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
Arrhythmogenic Cardiomyopathy (ACM) Market Research Report 2024: US and EU5 Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access
September 30, 2024 05:26 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Arrhythmogenic Cardiomyopathy (ACM) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access"...
Myodyal Infarction Market Forecast to Reach $3.43 Billion by 2032: Global Analysis by Drug Class, Distribution Channel, Region and Company
June 20, 2024 06:28 ET
|
Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global Myocardial Infarction Market Report by Drug Class, Distribution Channels, Regions and Company Analysis 2024-2032" report has been added to ...
ACE Inhibitors Market Forecasted to Surge to $9 Billion by 2028 Amid Growing Cardiovascular and Hypertension Concerns
January 31, 2024 09:37 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "ACE Inhibitors Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The global ACE inhibitors market is projected to...
Antihypertensive Drug Market to Expand with Promising CAGR of 4.7% through 2030: Regional Growth Opportunities for Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-Adrenergic Blockers
January 30, 2024 07:11 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Antihypertensive Drug Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Atherosclerotic Cardiovascular Disease Market Set to Exhibit Growth by 2032, Driven by Advancements and Emerging Therapies
January 24, 2024 10:32 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ...
Global Ischemic Heart Disease (IHD) Drugs Market Set to Expand, Projected Value of $7.9 Billion by 2028
September 21, 2023 09:58 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Ischemic Heart Disease Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Global Atherosclerosis Drugs Market to Reach $27.71 Billion by 2032, Driven by Rising Cardiovascular Disorders
September 13, 2023 10:28 ET
|
Research and Markets
Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Atherosclerosis Drugs Market By Drug Type, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast,...
North America Hemoglobinopathies Market Analysis Report 2022: Focus on Thalassemia and Sickle Cell Disease - Forecasts to 2028
March 07, 2023 10:33 ET
|
Research and Markets
Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "North America Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution...
Global Nephrology Drugs Market Projected to Garner a Revenue of $21,454.5 Million and Rise at a CAGR of 6.0% during the Forecast Period 2021-2028 [170-Pages] | Exclusive by Research Dive
February 06, 2023 09:01 ET
|
Research Dive
New York, USA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global nephrology drugs market is anticipated to generate a revenue of $21,454.5 million and...